- POSITIVE
Quarterly Revenue GSP Crop Science Jun-2026 Quarterly Revenue is Rs 434 Cr which is growth of 7.6% YoY.
- POSITIVE
Quarterly Net Profit GSP Crop Science Jun-2026 Quarterly Net Profit is Rs 31 Cr which is growth of 28.4% YoY.
NSE: GSPCROP | BSE: 544733
GSP Crop Science Live Share Price Today, Share Analysis and Chart
aboutGSP Crop Science Ltd. is an agrochemical manufacturer involved in the production of a wide range of crop protection products. The company operates across the value chain, from technical synthesis to the formulation of branded agrochemicals. With a fo... Read More
433.05-7.40(-1.68%)
263.1K
NSE+BSE Volume
NSE 30 Oct, 2026 3:31 PM (IST)
Falling CometThese stocks have good quality scores. However, their weak technicals make them more bearishView SimilarEmbed DVM
Please subscribe to view forecaster data
GSP Crop Science Stock Price Analysis
Day Price Range-1.7% 1 Day return | 433 (LTP) 432441.4 LowHigh |
|---|---|
Week Price Range-0.8% 1 Week return | 433 (LTP) 430463.6 LowHigh |
Month Price Range-7.3% 1 Month return | 433 (LTP) 430501.5 LowHigh |
52 Week Price Range35.3% 1 Year return | 433 (LTP) 328668 LowHigh |
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
GSP Crop Science quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| 434.4 | 439.5 | 279.6 | 504.6 | 403.8 | 337.1 | 297 | ||
Operating Exp. | 383.4 | 397.3 | 265.7 | 432.5 | 360.3 | 292.2 | 280.7 | |
Operating Profit | 40.8 | 32 | 11 | 67.2 | 39.9 | 36.6 | 15 | |
Operating Profit Margin % | 9.61% | 7.45% | 3.96% | 13.44% | 9.98% | 11.13% | 5.08% | |
Depr. | 4.6 | 4.2 | 4.8 | 3.5 | 3.9 | 4.8 | 4.9 | |
Interest | 5.6 | 8.8 | 8.3 | 7.7 | 7.4 | 7.6 | 7.6 | |
Profit Before Tax | 40.8 | 29.2 | -3.5 | 61 | 32.3 | 32.4 | 3.9 | |
Tax | 9.5 | 7.6 | -1 | 14.5 | 7.9 | 10.1 | -0.9 | |
Net Profit | 31.3 | 21.6 | -2.6 | 46.4 | 24.4 | 22.3 | 4.9 | |
EPS Adj. latest | 6.7 | 4.7 | -0.6 | 10 | 5.2 | 4.8 | 1.1 | |
Net profit TTM | 96.8 | 89.8 | 90.5 | 98 | - | - | - | |
Basic EPS TTM | 20.8 | 19.3 | 23.2 | 25.1 | - | - | - | |
Earnings Transcripts | ||||||||
Results PDF | ||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
GSP Crop Science Technical Analysis
GSP Crop Science EMA & SMA
Bearish-7
0 bullish, 7 bearish
Bullish0
Bearish7
| 5 Day | 441.6 |
|---|---|
| 10 Day | 448.1 |
| 12 Day | 450.6 |
| 20 Day | 460.7 |
| 26 Day | 468.2 |
|---|---|
| 50 Day | 487.3 |
| 100 Day | 480.0 |
GSP Crop Science Delivery And Volume
Daily Avg. Delivery Volume %
30 Oct, 202613.4%
Week24.1%
Month19.6%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
GSP Crop Science Resistance and Support
435.50
Pivot
| First Resistance | 439 |
|---|---|
| Second Resistance | 445.0 |
| Third Resistance | 448.5 |
| First Support | 429.6 |
|---|---|
| Second Support | 426.1 |
| Third Support | 420.1 |
| Day RSI | 33.2 |
|---|---|
| Day MACD | -17.6 |
| Day MFI | 31.9 |
| Day MACD Signal Line | -17.7 |
GSP Crop Science Beta
| 1 Month | 0.1 |
|---|---|
| 1 Year | - |
| 3 Month | 0.6 |
|---|---|
| 3 Year | - |
GSP Crop Science Price Change Analysis
↓-7.3%
Over 1 Month
LowHigh
430501.5
↓-25.7%
Over 3 Months
LowHigh
430668.0
↑2.8%
Over 6 Months
LowHigh
366.9668.0
↑35.3%
Over 1 Year
LowHigh
328668.0
GSP Crop Science Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SETU SECURITIES PRIVATE LIMITED | Bulk | Purchase | 06 Jul 2026 | 402.53 | 405,000 | NSE |
| LONGTHRIVE CAPITAL VCC - GAMMA VIEW FUNDS | Bulk | Sell | 07 Apr 2026 | 388.25 | 250,000 | NSE |
| PSL LIMITED | Bulk | Purchase | 07 Apr 2026 | 388.29 | 250,000 | NSE |
| SHINE STAR BUILD CAP PVT LTD | Bulk | Sell | 24 Mar 2026 | 328 | 1,030,479 | NSE |
| MAYBANK SECURITIES PTE LTD | Bulk | Sell | 24 Mar 2026 | 328 | 872,000 | NSE |
| SHARE INDIA SECURITIES LIMITED | Bulk | Sell | 24 Mar 2026 | 333.51 | 241,530 | NSE |
| AFFLUENCE GEMS PRIVATELIMITED | Bulk | Purchase | 24 Mar 2026 | 328.24 | 802,000 | NSE |
| ATRICHHAYA FINANCIAL PRIVATE LIMITED | Bulk | Purchase | 24 Mar 2026 | 328 | 390,000 | NSE |
| RHETAN ESTATE PRIVATE LIMITED | Bulk | Purchase | 24 Mar 2026 | 328 | 277,980 | NSE |
| MAANIT CONSULTANCY | Bulk | Purchase | 24 Mar 2026 | 328 | 308,000 | NSE |
GSP Crop Science Corporate Actions
GSP Crop Science Dividend history and yield
GSP Crop Science dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track GSP Crop Science dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
111 Sep 2026 | 1 | FINAL | 11 Sep 2026 | Equity Share |
GSP Crop Science Board Meetings
GSP Crop Science past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
111 Aug 2026 | Quarterly Results | - |
226 May 2026 | Audited Results & Final Dividend | - |
311 Apr 2026 | Quarterly Results | - |
GSP Crop Science Research Reports
GSP Crop Science research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 115 Mar 2026 | Hem Securities | - | - | IPO Subscribe | - | -% | |
| 212 Mar 2026 | Ventura | - | - | IPO Subscribe | - | -% | |
| 311 Mar 2026 | SBI Securities | - | - | IPO Note | - | -% |
GSP Crop Science Corporate Filings
GSP Crop Science BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 15 Oct 2026 | GSP Crop Science Ltd - 544733 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Certificate under regulations 74(5) of SEBI (DP) Regulations, 2018 | |
| 12 Oct 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Change in Management | Mr. Pranav Chitre, Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company has tendered his resignation vide letter dated October 12, 2026. He shall cease to hold office of CFO and KMP of the Company with effect from the close of Business Hours on October 30, 2026. | |
| 12 Oct 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | Mr. Pranav Chitre, Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company has tendered his resignation vide letter dated October 12, 2026. He will cease to hold office of CFO and KMP of the Company with effect from the close of business hours on October 30, 2026. | |
| 28 Sep 2026 | GSP Crop Science Ltd - 544733 - Closure of Trading Window | Trading Window for dealing in securities of the Company shall remain closed with effect from October 1, 2026 and shall remain closed until 48 hours after the announcement of the Unaudited Financial Result of the Company for the quarter and half year ended September 30, 2026. | |
| 22 Sep 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | GSP Crop Science Limited has informed the exchange about schedule of investor meet. |
GSP Crop Science Documents
GSP Crop Science Earnings Call
GSP Crop Science earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 17 Aug 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 13 Aug 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Link |
| 12 Aug 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Link |
| 20 Apr 2026 | GSP Crop Science Ltd - 544733 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
GSP Crop Science Annual Reports
GSP Crop Science financials, including annual results, balance sheets, and cash flow statements.
| Date | Report Title | Links |
|---|---|---|
| 2026 | Annual Report Mar-2026 | Link |
GSP Crop Science Investor Presentations
GSP Crop Science investor presentations, including business updates, financial insights, and strategic initiatives.
GSP Crop Science - Company Profile
GSP Crop Science Management Structure
GSP Crop Science management structure with salaries, total experience, and qualifications.
GSP Crop Science Board of Directors
GSP Crop Science Board of directors with salaries, total experience, and qualifications.
Website: www.gspcrop.in
About the company - Business Profile
GSP Crop Science Ltd. is an agrochemical manufacturer involved in the production of a wide range of crop protection products. The company operates across the value chain, from technical synthesis to the formulation of branded agrochemicals. With a focus on research and development, GSP Crop Science maintains a significant presence in both the domestic Indian market and international geographies, providing solutions including insecticides, herbicides, fungicides, and plant growth regulators.
Key Points
- Key Facts:
- Headquarters: Ahmedabad, Gujarat.
- Status: Formally known as GSP Crop Science Private Limited; now GSP Crop Science Limited.
- Key Products: Insecticides, Herbicides, Fungicides, and Plant Growth Regulators (PGRs).
- Registered Office: 404, Lolita Complex, Ahmedabad.
- Operations and Resources:
- The company operates five manufacturing facilities in India:
- Odhav Facility (Gujarat): Formulations (27,132 MT) and Technicals (3,960 MT).
- Kathwada Facility (Gujarat): Formulations (6,000 MT).
- Nandesari Facility (Gujarat): Technicals (11,160 MT).
- Samba Facility (J&K): Formulations (10,540 MT).
- Saykha Facility (Gujarat): Intermediates (5,400 MT).
- Certifications: ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018.
- The company operates five manufacturing facilities in India:
- Market and Significance:
- Domestic Presence: Operates in 23 states with a strong dealer/distributor network.
- International Presence: Global reach across 37 countries, including planned sales in Brazil, USA, and Africa.
- Portfolio: 219 formulation registrations and 63 technical registrations in the domestic market. Internationally, it holds 176 formulation and 60 technical registrations.
- Business Model and Innovation:
- GSP Crop Science follows an IP-driven business model with a heavy focus on R&D and patenting.
- Intellectual Property: 102 granted patents and 108 applications under process. It holds 10 exclusive process patents for technical products.
- Strategic Capabilities: Expertise in technical synthesis and special formulations.
- Financial Overview (FY 2024-25):
- Revenue from Operations: ₹14,086.94 million (Audited for Year Ended March 31, 2025).
- Profit Before Tax: ₹1,015.88 million (FY25).
- Profit After Tax: ₹763.07 million (FY25).
- Revenue Trend: For the nine months ended December 31, 2025, the company reported revenues of ₹11,765.81 million compared to ₹10,798.90 million in the corresponding previous period.
- International Growth: International business revenue grew by 20% over the previous year, supported by new registrations like Chlorpyriphos in Brazil.
- Key Products and Advancements:
- Key Brands: SLR 525, Platform, PCT-410, All Rounder, Afford, Aurthor, Liger, Raavan, and Element.
- Recent Launches: One patented Insecticide + Fungicide mixture in Paddy and two "me-too" herbicides for Maize and Soybean in the India B2C market.
- Advanced R&D: Initiated work on two futuristic insecticides and one herbicide active ingredient to ensure early market entry upon patent expiration of the original molecules.
- Current Strategic Initiatives:
- Geographical Expansion: Expanded sales operations into Kerala to focus on plantation crops.
- Regulatory Focus: Pursuing source registrations in Brazil, Africa, Middle East, and Asian countries. Specifically focusing on Chlorantraniliprole and Methoxyfenozide registrations.
- Capacity Utilization: Continuous investment in manufacturing infrastructure to maintain its position in the technical synthesis market.
References